Personalized Adoptive Immunotherapy/Clavic-Q-RE (aka. VAXO-Q-RE)

Before therapy begins, we run two prerequisite blood tests to confirm your eligibility and establish a baseline: Immune Frame — a comprehensive assessment of your immune system; Oncotrace — a circulating tumour cell (CTC) count to measure your cancer's activity; These tests require a simple blood draw and are not included in the therapy package cost.

Once eligible, your blood is collected and sent to RGCC's laboratory, where your immune cells are isolated, expanded, and activated over approximately 21 days. Your therapy is made exclusively from your own cells.

Clavic-Q-RE is delivered in three doses, administered at The Upper Room Clinic: Day 0 — Dose 1: Macrophages and Natural Killer cells; Day 15 — Dose 2: Dendritic cells, cytotoxic T-lymphocytes, and plasma cells; Day 30 — Dose 3: Tailored by RGCC based on your individual immune response. Each infusion is delivered by slow IV push, preceded by pre-medications to support your comfort and safety. The process takes approximately 1–2 hours per visit.

Two rounds of mandatory follow-up testing are included in your therapy package to monitor your immune response and treatment progress: Day 120 — Immune Frame and Oncotrace; Day 210 — Immune Frame and Oncotrace.